Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

(2011) S. M. Kornblau et al.   BLOOD

RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia

(2011) M. Holland et al.   BLOOD

Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia

(2010) K. Csomos et al.   BLOOD

The requirement for proteomics to unravel stem cell regulatory mechanisms

(2010) Andrew J.K. Williamson et al.   JOURNAL OF CELLULAR PHYSIOLOGY

High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event

(2010) R Quéré et al.   LEUKEMIA

Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells

(2010) Anupam Kumar et al.   PLoS One

Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity

(2009) Minati Satpathy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells

(2009) G -Y Jang et al.   ONCOGENE

Functional proteomic profiling of AML predicts response and survival

(2008) S. M. Kornblau et al.   BLOOD

Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma

(2008) J. Y. Hwang et al.   CANCER RESEARCH

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling

(2008) L. Cao et al.   CARCINOGENESIS